文献速递肺外科

早期非小细胞肺癌肺段切除与肺叶切除的系统综述与Meta分析

Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

在I期和IA期,肺叶切除在总生存、癌症特异性生存和无复发生存上均更优;但在肿瘤<2cm的IA期,两组结局无显著差异,提示肺段切除可能是有价值的替代选择。

要点

  • I期和IA期NSCLC,肺叶切除的肿瘤学结局优于肺段切除。
  • 肿瘤<2cm的IA期,肺段切除与肺叶切除的结局无显著差异。
  • 肺段切除可能作为<2cm NSCLC的替代选择。

核心结论

  • 在I期和IA期NSCLC中,肺叶切除的肿瘤学结局优于肺段切除。
  • 在肿瘤<2cm的IA期NSCLC中,肺段切除与肺叶切除的肿瘤学结局无显著差异。
  • 肺段切除可能作为<2cm NSCLC的有价值替代选择。

研究设计与样本

  • 检索报告总生存(OS)、癌症特异性生存(CSS)或无复发生存(RFS)的文献。
  • 采用逆方差加权法合并风险比(HR)。

主要发现

  • I期:肺段切除对比肺叶切除,OS的HR为1.25(P=0.01),CSS的HR为1.59(P=0.02),RFS的HR为1.40(P<0.001)。
  • IA期:OS的HR为1.31(P=0.04),CSS的HR为1.56(P=0.02),RFS的HR为1.22(P=0.11)。
  • IA期<2cm:OS的HR为1.13(P=0.37),CSS的HR为1.02(P=0.95),RFS的HR为1.24(P=0.11)。

临床怎么用

  • 对于I期和IA期NSCLC,肺叶切除仍应作为首选术式。
  • 对于肿瘤<2cm的IA期NSCLC,可考虑肺段切除作为替代选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The role of segmentectomy in early-stage non-small-cell lung cancer (NSCLC) remains a matter of debate. We performed a meta-analysis to evaluate the oncological outcomes following segmentectomy versus lobectomy for stage I, stage IA only and stage IA <2 cm only. METHODS: We systematically searched the literature for articles reporting on overall survival (OS), cancer-specific survival (CSS) or recurrence-free survival (RFS). The hazard ratios (HRs) were retrieved and pooled using an inverse variance-weighted approach. RESULTS: Twenty-eight studies were included in the analysis. In stage I, segmentectomy was found to be inferior to lobectomy for all 3 outcomes with HR: 1.25 (P = 0.01) for OS, 1.59 (P = 0.02) for CSS and 1.40 (P < 0.001) for RFS. In stage IA, the differences were significant for OS and CSS, though not for RFS with HR: 1.31 (P = 0.04), 1.56 (P = 0.02) and 1.22 (P = 0.11), respectively. In stage IA <2 cm, no significant differences were found between segmentectomy and lobectomy with HR: 1.13 (P = 0.37) for OS, 1.02 (P = 0.95) for CSS and 1.24 (P = 0.11) for RFS. CONCLUSIONS: For stages I and IA, lobectomy showed superior results whereas for tumours <2 cm, our study did not find significant differences in oncological outcomes between both groups. These results suggest that segmentectomy might be a valuable alternative to lobectomy for NSCLC in tumours <2 cm.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Winckelmans T, Decaluwé H, De Leyn P, et al. Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2020. PMID: 31898738. doi:10.1093/ejcts/ezz339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。